Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Immuneering Corporation Class A Common Stock (IMRX)

Pharmaceutical Preparations

https://www.immuneering.com

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.

245 MAIN STREET, SECOND FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

30,246,468

Shares Outstanding

29,270,000

Weighted SO

29,269,121

Total Employees

N/A

Upcoming Earnings

08/01/2024

Beta

-0.6150

Last Div

0.0000

Range

1.0-10.25

Chg

-0.0600

Avg Vol

1553519

Mkt Cap

30246468

Exch

NASDAQ

Country

US

Phone

617 500 8080

DCF Diff

-0.8535

DCF

1.9335

Div Yield

0.0000

P/S

-0.3203

EV Multiple

0.0018

P/FV

0.4562

Div Yield %

0.0000

P/E

-0.5395

PEG

1.0088

Payout

0.0000

Current Ratio

9.3917

Quick Ratio

9.3917

Cash Ratio

8.8081

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1286.1651

CCC

-1286.1651

Gross Margin

1.0079

Op Margin

0.6404

Pretax Margin

0.5938

Net Margin

0.5938

Eff Tax Rate

248.1519

ROA

-0.7273

ROE

-0.6603

ROCE

-0.8601

NI/EBT

1.0000

EBT/EBIT

0.9272

EBIT/Rev

0.6404

Debt Ratio

0.0559

D/E

0.0650

LT Debt/Cap

0.0569

Total Debt/Cap

0.0611

Int Coverage

-0.0562

CF/Debt

-11.7855

Equity Multi

1.1626

Rec Turnover

0.0000

Pay Turnover

0.2838

Inv Turnover

0.0000

FA Turnover

-18.4483

Asset Turnover

-1.2248

OCF/Share

-1.7138

FCF/Share

-1.7238

Cash/Share

2.0142

OCF/Sales

0.5382

FCF/OCF

1.0059

CF Coverage

-11.7855

ST Coverage

-163.1649

CapEx Coverage

-170.3523

Div&CapEx Cov

-170.3523

P/BV

0.4562

P/B

0.4562

P/S

-0.3203

P/E

-0.5395

P/FCF

-0.5917

P/OCF

-0.5952

P/CF

-0.5952

PEG

1.0088

P/S

-0.3203

EV Multiple

0.0018

P/FV

0.4562

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation